Retension Pharmaceuticals, Inc. IPO Research Information

Retension Pharmaceuticals, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Retension Pharmaceuticals, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Retension Pharmaceuticals, Inc.	RTSN - NASDAQ	$11.00-$13.00	$12.00	$10.00	3.75 million	10/9/2026
Underwriter(s): Leerink Partners, Guggenheim Securities, Oppenheimer & Co., Titan Partners
Co-Manager(s):
Industry: Health Care
Filing(s): Filed 2026-09-18 Terms Added 2026-10-05

Retension Pharmaceuticals, Inc. Quote & Chart - Click for current quote - RTSN

About Retension Pharmaceuticals, Inc. (adapted from Retension Pharmaceuticals, Inc. prospectus):
They are a clinical-stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular diseases.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "RTSN" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.